![Nitin Gore](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nitin Gore
Plus aucun poste en cours
Profil
Nitin Gore worked as a Principal at Wockhardt Ltd., a Controller at Emcure Pharmaceuticals Ltd., and a Chief Quality Officer at RPG Life Sciences Ltd.
He received his undergraduate, graduate, and doctorate degrees from the University of Mumbai.
Anciens postes connus de Nitin Gore
Sociétés | Poste | Fin |
---|---|---|
WOCKHARDT LIMITED | Corporate Officer/Principal | - |
RPG LIFE SCIENCES LIMITED | Corporate Officer/Principal | - |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Comptroller/Controller/Auditor | - |
Formation de Nitin Gore
University of Mumbai | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
Sociétés cotées | 2 |
---|---|
WOCKHARDT LIMITED | Health Technology |
RPG LIFE SCIENCES LIMITED | Health Technology |
Entreprise privées | 1 |
---|---|
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |